Back to the main directory
EarningsReview / Equity
- Building the value proposition by BNP Paribas Exane
- Resetting expectations (once again) by BNP Paribas Exane
- Q324 results and 15 questions for management by BNP Paribas Exane
- Still waiting for lift-off by BNP Paribas Exane
- Soft 3Q24 results, FY24 guidance narrowed by BNP Paribas Exane
- 3Q24 Preview: Thoughts ahead of the print by BNP Paribas Exane
- Results on track to achieve FY24 guidance, as expected by BNP Paribas Exane
- Austevoll Seafood (Buy, TP: NOK123.00) - Peruvian comeback continues by DnB Markets
- Vestas Wind Systems (Buy, TP: DKK215.00) - Service, service and service by DnB Markets
- XXL ASA (No_rec, TP: NOK) - Recommendation and target price withdrawn by DnB Markets
- Sampo Oyj (Buy, TP: EUR48.00) - Pricing power remains strong by DnB Markets
- Ambea (Buy, TP: SEK120.00) - Margin approaching 9.5% already by DnB Markets
- Sinch (Buy, TP: SEK33.00) - Remains a BUY on valuation by DnB Markets
- Higher terminal value? by BNP Paribas Exane
- Q3 2024 First Take: EBITDA in line, Retail guide trimmed again by BNP Paribas Exane
- Coupang Inc (CPNG US) by HSBC
- Teleperformance (TEP FP) by HSBC
- M&S (MKS LN) by HSBC
- Aker Horizons - Q3 affected by unfavourable market events by Danske Bank Equity Research
- Sinch - Hold: Expecting a slow start to 2025 by Nordea
- Licensing stronger and V9 royalty adoption on-track by BNP Paribas Exane
- Aker ASA - Buy/NOK 850 (900): The dividend machine by Nordea
- Prisma Properties - Buy/SEK 32: More acquisitions could be the next trigger by Nordea
- Political and spending overhang emerging? by BNP Paribas Exane
- Onward and Upward: Risk-Reward Favorable Post Messy 3Q; “Self-Help” Options on the Table by BNP Paribas Exane
- Q3 results: bullish cat by BNP Paribas Exane
- The Electoral & Share Price Red Wave by BNP Paribas Exane
- Q324 results and 15 questions for management by BNP Paribas Exane
- TDY acquires Excelitas’ A&D assets for $710m in accretive deal by BNP Paribas Exane
- Signs of improving momentum by BNP Paribas Exane
- FY25 guidance raised post 1Q by BNP Paribas Exane
- Norwegian Air Shuttle (Buy, TP: NOK14.00) - October traffic statistics by DnB Markets
- Ambu (Buy, TP: DKK140.00) - Solid guidance considering soft Q4 by DnB Markets
- Multiconsult (Buy, TP: NOK220.00) - Targeting international growth by DnB Markets
- Skanska (Buy, TP: SEK260.00) - Asset sales remain key catalyst by DnB Markets
- Novo Nordisk (Buy, TP: DKK1150.00) - Wegovy roll-out boost by DnB Markets
- Mowi (Buy, TP: NOK235.00) - Q3 in line, with a good outlook by DnB Markets
- Genmab (Buy, TP: DKK2500.00) - Still awaiting CD-38 decision by DnB Markets
- Q3 a significant miss, small cons cuts likely and shares could reverse recent gains by BNP Paribas Exane
- First Take 3Q24: EPS 6% above, improved FY24 EPS guide implies 1% cons. upgrades by BNP Paribas Exane
- Autohome Inc (ATHM US) by HSBC
- Sage Group Plc (SGE LN) by HSBC
- NNIT - Margin improvements expected from Q4 by Danske Bank Equity Research
- Pandora - Hold: Solid result overshadowed by margin headwinds by Nordea
- Regulatory pressure to ease under new US administration? by BNP Paribas Exane
- First Take On SeptQ Results And DecQ Guide by BNP Paribas Exane
- Genmab - Hold: It's still a waiting game by Nordea
- Ambitions ramping up - we upgrade to Neutral by BNP Paribas Exane
- ‘New Azure’ to see more share gains vs AWS by BNP Paribas Exane
- Ambea - Buy/SEK 106 (98): Altiden is the final piece of the puzzle by Nordea